109 related articles for article (PubMed ID: 30684568)
1. T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
Roca AM; Chobrutskiy BI; Callahan BM; Blanck G
Hum Immunol; 2019 Apr; 80(4):237-242. PubMed ID: 30684568
[TBL] [Abstract][Full Text] [Related]
2. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
[TBL] [Abstract][Full Text] [Related]
3. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Tong WL; Callahan BM; Tu YN; Zaman S; Chobrutskiy BI; Blanck G
Breast Cancer Res Treat; 2019 Jan; 173(1):167-177. PubMed ID: 30229447
[TBL] [Abstract][Full Text] [Related]
4. TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates.
Clark KR; Tong WL; Callahan BM; Yavorski JM; Tu YN; Blanck G
Int J Immunogenet; 2019 Feb; 46(1):31-37. PubMed ID: 30474304
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates.
Callahan BM; Tong WL; Blanck G
Immunol Res; 2018 Apr; 66(2):219-223. PubMed ID: 29594966
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns.
Callahan BM; Yavorski JM; Tu YN; Tong WL; Kinskey JC; Clark KR; Fawcett TJ; Blanck G
Cancer Immunol Immunother; 2018 Jun; 67(6):885-892. PubMed ID: 29508024
[TBL] [Abstract][Full Text] [Related]
7. Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates.
Huda TI; Mihyu M; Gozlan EC; Arndt MF; Diaz MJ; Zaman S; Chobrutskiy BI; Blanck G
Leuk Lymphoma; 2021 Jul; 62(7):1711-1720. PubMed ID: 33622167
[TBL] [Abstract][Full Text] [Related]
8. Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
Chobrutskiy BI; Zaman S; Tong WL; Diviney A; Blanck G
J Neurooncol; 2018 Dec; 140(3):697-704. PubMed ID: 30382482
[TBL] [Abstract][Full Text] [Related]
9. Immune DNA signature of T-cell infiltration in breast tumor exomes.
Levy E; Marty R; Gárate Calderón V; Woo B; Dow M; Armisen R; Carter H; Harismendy O
Sci Rep; 2016 Jul; 6():30064. PubMed ID: 27452728
[TBL] [Abstract][Full Text] [Related]
10. TCR gene segment usage and HLA alleles that are associated with cancer survival rates also represent racial disparities.
Angelakakis G; Serraneau KS; Barker VR; Callahan BM; Tong WL; Zaman S; Huda TI; Blanck G
Int J Immunogenet; 2023 Apr; 50(2):41-47. PubMed ID: 36585798
[TBL] [Abstract][Full Text] [Related]
11. Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.
Lobashevsky A; Kotb M; Gaber AO
Transplantation; 1996 Nov; 62(9):1332-40. PubMed ID: 8932281
[TBL] [Abstract][Full Text] [Related]
12. From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity.
Paaso A; Jaakola A; Syrjänen S; Louvanto K
Acta Cytol; 2019; 63(2):148-158. PubMed ID: 30783048
[TBL] [Abstract][Full Text] [Related]
13. B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
Tu YN; Tong WL; Callahan BM; Chobrutskiy BI; Blanck G
Anticancer Res; 2020 Apr; 40(4):2043-2051. PubMed ID: 32234895
[TBL] [Abstract][Full Text] [Related]
14. Somatic Variation of T-Cell Receptor Genes Strongly Associate with HLA Class Restriction.
Klarenbeek PL; Doorenspleet ME; Esveldt RE; van Schaik BD; Lardy N; van Kampen AH; Tak PP; Plenge RM; Baas F; de Bakker PI; de Vries N
PLoS One; 2015; 10(10):e0140815. PubMed ID: 26517366
[TBL] [Abstract][Full Text] [Related]
15. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
Samy MD; Tong WL; Yavorski JM; Sexton WJ; Blanck G
Cancer Immunol Immunother; 2017 Mar; 66(3):403-410. PubMed ID: 27995306
[TBL] [Abstract][Full Text] [Related]
17. A risk evaluation model of cervical cancer based on etiology and human leukocyte antigen allele susceptibility.
Hu B; Tao N; Zeng F; Zhao M; Qiu L; Chen W; Tan Y; Wei Y; Wu X; Wu X
Int J Infect Dis; 2014 Nov; 28():8-12. PubMed ID: 25223804
[TBL] [Abstract][Full Text] [Related]
18. TcR-α recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers.
Mai AT; Tong WL; Tu YN; Blanck G
Int Immunol; 2018 Feb; 30(1):35-40. PubMed ID: 29361059
[TBL] [Abstract][Full Text] [Related]
19. Limited restriction in the TCR-alpha beta V region usage of antigen-specific clones. Recognition of myelin basic protein (amino acids 84-102) and Mycobacterium bovis 65-kDa heat shock protein (amino acids 3-13) by T cell clones established from peripheral blood mononuclear cells of monozygotic twins and HLA-identical individuals.
Hawes GE; Struyk L; Godthelp BC; van den Elsen PJ
J Immunol; 1995 Jan; 154(2):555-66. PubMed ID: 7529279
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]